Skip to main content
SpringerLink
Log in

Ambulante Langzeitbehandlung

  • Chapter
Diabetes bei Kindern und Jugendlichen

  • 1099 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • AGPD (Arbeitsgemeinschaft für Pädiatrische Diabetologie; Hürter P, Holl RW, Burger W, Schober E, Klinghammer A) (1995) Qualitätssicherung in der pädiatrischen Diabetologie. Diab Stoffw 4: 481–485 und Monatsschr Kinderheilk 143: 1146-1149

    Google Scholar 

  • AGPD (Arbeitsgemeinschaft für Pädiatrische Diabetologie; Hecker W, Holl RW, Kordonouri O, Lang E, Lange K) (2004) Stellungnahme der Arbeitsgemeinschaft pädiatrische Diabetologie zur Jet-Injektion.Diabetes und Stoffwechsel 14: 58–59

    Google Scholar 

  • AGPD (Arbeitsgemeinschaft für Pädiatrische Diabetologie; Heidtmann B, Ziegler R, Beyer P et al.) (2004) Statement: Insulinpumpentherapie (CSII) bei Kindern und Jugendlichen mit insulinpflichtigem Diabetes mellitus. Diabetes und Stoffwechsel 14: 62–63

    Google Scholar 

  • Ahern JH, Boland EA, Doane R, Vincent MR, Tamborlane WV (2001) Pumps in kids:safe and successful. Diabetes 50(Suppl 2): A66

    Google Scholar 

  • Åkerblom HK (1980) Definition of remission in insulin-dependent, juvenile-onset diabetes mellitus (JDDM). Acta Paediatr Belg 33: 66

    Google Scholar 

  • American Diabetes Association (1988) Position statement on jet injectors. Diabetes Care 11: 600

    Google Scholar 

  • American Diabetes Association (1996) Clinical practice recommendations. Diabetes Care 19(Suppl 1): 8–15

    Google Scholar 

  • Ammon HPT, Schatz H (1995) Verlautbarung der Deutschen Diabetes-Gesellschaft zur subkutanen Insulinapplikation. Diab Stoffw 4: 382

    Google Scholar 

  • Bartus B (2003) Psychologische Aspekte der Insulinpumpen-therapie bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1. Therapief Diab 2: 10–15

    Google Scholar 

  • Benedetti A, Cattano G, Macor S, Noacco C (1975) Cheiroarthropathy of juvenile diabetes. Diabetologia 11: 332

    Google Scholar 

  • Beyer J, Dieterle P, Gries FA, Hepp KD, Otto H, Schöffling K (1985) Therapie des Diabetes mellitus:Einstellungskriterien und Erfolgskontrollen. Diabetol Inf 7: 14–18

    Google Scholar 

  • Bittner C, Lüpke K, Schütz W von, Danne T (2003) Which children with type 1 diabetes profit from insulin pump therapy? JPEM 16(Suppl 4): 925

    Google Scholar 

  • Bode BW, Steed RD, Davidson PC (1996) Reduction in severe hypoglycemia with long-term subcutaneous insulin infusion in type 1 diabetes. Diabetes Care; 19:324–7

    PubMed  CAS  Google Scholar 

  • Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV (1999) Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22: 1779–1784

    PubMed  CAS  Google Scholar 

  • Bruck E, MacGillivray MH (1974) Post-hypoglycemic hyperglycemia in diabetic children.J Pediatr 84: 672

    Article  PubMed  CAS  Google Scholar 

  • Bundesgesetzblatt (1985) Bundesgesetzblatt Teil I, Bd 28.Bundesanzeiger, Köln, S. 186f

    Google Scholar 

  • Burger W, Weber B (1994) Betreuung von Kindern und Jugendlichen mit Diabetes mellitus. Anspruch und Realität. Der Kinderarzt 25: 578–584

    Google Scholar 

  • Burger W, Weber B, Ender I, Hartmann R (1991) Therapie des Diabetes mellitus im Kindes-und Jugendalter. Monatsschr Kinderheilkd 139: 62–68

    PubMed  CAS  Google Scholar 

  • Campbell PJ, Bolli GB, Cryer PE, Gerich JE (1985) Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. New Engl J Med 312: 1473

    Article  PubMed  CAS  Google Scholar 

  • Celona-Jacobs N, Weinzimer S, Pearson M, Hartz D, Katz L, Murphy K (2001) Insulin pump therapy in children:a cautionary tale Diabetes 50(Suppl 2): A67

    Google Scholar 

  • Colquitt J, Royle P, Waugh N (2003) Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet Med. 20: 863–866

    Article  PubMed  CAS  Google Scholar 

  • Conrad SC, McGrath MT, Gitelman SE (2002) Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus.J Pediatr 140: 235–240

    Article  PubMed  Google Scholar 

  • Cryer PE, Binder C, Bolli GB, Cherrington AD, Gale EAM, Gerich JE, Sherwon RS (1989) Hypoglycemia in IDDM.Diabetes 38: 1193

    PubMed  CAS  Google Scholar 

  • Daikeler R (2003) Insulinpumpentherapie — eine Kostenfrage? Therapief Diab 2: 21–23

    Google Scholar 

  • Danne T, Mortensen HB, Hougaard P et al. (2001) Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3, 805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care 24: 1342–1347

    PubMed  CAS  Google Scholar 

  • Danne T, Battelino T, Hanas R, Kordonouri O, Phillip M and the Pedpumps Study Group (in Druck)Ninety day memory read-out from 370 international pediatric patients demonstrate the safety and flexibility of continuous subcutaneous insulin infusion (CSII) in all age groups.

    Google Scholar 

  • DCCT (Diabetes Control and Complications Trial Research Group) (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med 329: 977–986

    Article  Google Scholar 

  • DCCT (Diabetes Control and Complications Trial Research Group) (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial. J Pediatr 125: 177–188

    Article  Google Scholar 

  • DCCT (Diabetes Control and Complications Trial Research Group) (1995) The relationship of glycemic exposure (HbA1c )to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968–983

    Google Scholar 

  • De Beaufort CE, Houtzagers CM, Bruining GJ et al. (1989) Continuous subcutaneous insulin infusion (CSII)versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 6: 766–771

    PubMed  Google Scholar 

  • DeWitt DE, Hirsch IB (2003) Outpatient insulin therapy in type 1 and type 2 diabetes mellitus. JAMA 289: 2254–2264

    Article  PubMed  CAS  Google Scholar 

  • Diabetes-Leitlinie DDG Pädiatrie (2004) Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes-und Jugendalter. Diabetes Stoffw 13: 37–47

    Google Scholar 

  • Dorchy H, Roggemans MP, Willems D (1997) Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 20: 239–244

    Google Scholar 

  • Drash AL (1985) Current approaches to management and assessment of control of diabetes mellitus in childhood. In: Lifshitz F (ed) Pediatric endocrinology. A clinical guide, Dekker, New York, p 415

    Google Scholar 

  • Drash AL (1993) The child, the adolescent, and the Diabetes Control and Complications Trial. Diabetes Care 16:1515–1516

    PubMed  CAS  Google Scholar 

  • Dunger DB, Edge JA (1995) Glucose homeostasis in the normal adolescent. In: Kelnar CJH (ed) Childhood and adolescent diabetes. Chapman & Hall, London, p 31–45

    Google Scholar 

  • Dunger DB, Edge JA, Pal R et al.(1991) The impact of increased growth hormone secretion on carbohydrate metabolism in the adolescent diabetic. Acta Paed Scand 377: 69–77

    CAS  Google Scholar 

  • Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP (1990a) Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrin 71: 1356–1362

    CAS  Google Scholar 

  • Edge JA, Matthews DR, Dunger BD (1990b) The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrin 33: 729–737

    CAS  Google Scholar 

  • European IDDM Policy Group (1993) Consensus guidelines for the management of insulin-dependent (type I) diabetes. Meicom, Bussum/NL

    Google Scholar 

  • Fanelli CG, Pampenelli S, Porcellati F, Rossetti P, Brunetti P, Bolli GB (2002) Administration of neutral protamin Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. Ann Intern Med 136: 504–514

    PubMed  CAS  Google Scholar 

  • Ferguson SC, Strachan MW, James JM, Frier BM (2001) Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia. Diabetes Metab Res Rev 17: 285–291

    Article  PubMed  CAS  Google Scholar 

  • Francis AJ, Home PD, Hanning I, Alberti KG, Tunbridge WM (1983) Intermediate acting insulin given at bedtime. BMJ 286: 1173–1176

    PubMed  CAS  Google Scholar 

  • Gale EAM, Tattersall RB (1979) Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 197/I: 1049

    Article  Google Scholar 

  • Gnanalingham MG, Newland P, Smith CP (1998) Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child 79: 59–62

    PubMed  CAS  Google Scholar 

  • Guthrie RA, Murthy DYN, Womack WN, Jackson RL (1969) Insulin resistance in diabetes in juveniles. A case report in a child and review of literature.Pediatrics 40: 642

    Google Scholar 

  • Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Rosenfeld R, Tauber JP (1996) Insulin therapy and GH-IGF-I axis disorders in diabetes:impact of glycaemic control and hepatic insulinization.Diabetes Metab 4: 245–250

    Google Scholar 

  • Hanas R, Carlsson S, Frid A, Ludvigsson J (1997) Unchanged insulin absorption after 4 days’ use of subcutaneous indwelling catheters for insulin injections.Diabetes Care 20: 487–490

    PubMed  CAS  Google Scholar 

  • Hanas R, Ludvigsson J (1997) Experience of pain from insulin injections and needle phobia in young patients with insulin-dependent diabetes mellitus. Pract Diabetes 14: 95–99

    Google Scholar 

  • Hanas R, Stanke C-G, Östberg H (2000) Diagnosis of the cause of malfunction of indwelling catheters for insulin injections by the use of digital fluoroscopy. Pediatr Radiol 30: 674–676

    Article  PubMed  CAS  Google Scholar 

  • Hecker W, Holl RW, Kordonouri O, Lang E, Lang K (2004) Stellungnahme der Arbeitsgemeinschaft Pädiatrische Diabetologie zur Jet-Injektion. Diabetes Stoffw 13: 58f

    Google Scholar 

  • Heidtmann B, Holl RW (2003) Insulinpumpentherapie bei Kindern und Jugendlichen. Übersicht zur Entwicklung, Erfolg und Besonderheiten dieser Therapieform. Therapie Diab 2: 3–9

    Google Scholar 

  • Heinze E, Holl RW (1993) Die Deklaration von Saint Vincent: Diabetes-Betreuung und-Forschung in Europa. Monatsschr Kinderheilk 141: 348–350

    Google Scholar 

  • Henrichs HR (2003) Diabetestherapie mit Insulinpumpen. Unimed, Bremen

    Google Scholar 

  • Hepp KD, Renner R, Funcke HJ, Mehnert H, Haerten R, Kresse H (1977) Glucose homeostasis under continuous intravenous insulin therapy in diabetics. Horm Metab Res Suppl 7: 72–76

    Google Scholar 

  • Hildebrandt P, Birch K, Jensen BM, Kuhl C (1986) Subcutaneous insulin infusion:change in basal infusion rate has no immediate effect on insulin absorption rate. Diabetes Care 9: 561–564

    PubMed  CAS  Google Scholar 

  • Hindmarsh PC, Mathews DR, Brook CDG (1988) Growth hormone secretion in children determined by time series analysis. Clin Endocrin (Oxford) 29: 35–44

    CAS  Google Scholar 

  • Holl RW, Heinze E (1992) Dawn-oder Somogyi-Phänomen? Hohe morgendliche Nüchternblutzuckerwerte bei jugendlichen Typ-I-Diabetikern. Dtsch Med Wschr 117: 1503–1507

    Article  PubMed  CAS  Google Scholar 

  • Houtzargers CMGJ, Berntzen PA, van der Stap H, Heine RJ, van der Veen EA (1988) Absorption kinetics of short-and intermediate-acting insulin after jet injection with Medi-Jector II. Diabetes Care 11: 739

    Google Scholar 

  • Hürter P, Lange K (2001) Kinder und Jugendliche mit Diabetes. Medizinischer und psychologischer Ratgeber für Eltern. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • ISPAD (International Society for Pediatric and Adolescent Diabetes, International Diabetes Federation World Health Organisation) (2000) Consensus guidelines for the management of insulin-dependent (type I) diabetes mellitus (IDDM)in childhood and adolescence.Swift PGF (ed) Medforum,Zeist/NL,www.ispad.org,deutsche Fassung: www.disetronic.de/download/0701_B_ISPAD.pdf

    Google Scholar 

  • Jehle PM, Micheler C, Jehle DR, Breitig D, Boehm BO (1999) Inadequate suspension of neutral protamine Hagendorn (NPH)insulin in pens. Lancet 354: 1604–1607

    Article  PubMed  CAS  Google Scholar 

  • Juneja R, Hirsch IB, Naik RG et al.(2001) Islet cell antibodies and glutamic acid decarboxylase antibodies,but not the clinical phenotype,help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.Metabolism 50: 1008–1013

    Article  PubMed  CAS  Google Scholar 

  • Kaufman FR, Halvorson M, Fisher L, Pitukcheewanont P (1999) Insulin pump therapy in type 1 pediatric patients. J Pediatr Endocrinol Metab 12(Suppl 3): 759–764

    PubMed  Google Scholar 

  • Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P (2000) Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care 23:579–582

    PubMed  CAS  Google Scholar 

  • Klinkert C, Vortherms J, Hertrampf K, Lotz N, Petzold R (2000) Erfolgreiche Insulinpumpentherapie für Jugendliche mit Diabetes.Exp Clin Endocrinol Diabetes 108(Suppl 1): 182

    Google Scholar 

  • Krieger DR, Aschoff J (1979) Endocrine and other biological rhythms.In: De Groot L et al.(eds) Endocrinology. Vol.3, Grune & Stratton, New York, p 2079

    Google Scholar 

  • Laffel L, Loughlin C, Ramchan-Dani N, Butler D, Laffel N, Levine B, Anderson B (2001) Glycemic challenges of pump therapy in youth with type-1 diabetes. Diabetes 50(Suppl 2): A66–A67

    Google Scholar 

  • Lang DA Matthews DR, Burnett M, Ward GM, Turner RC (1982) Pulsatile,synchronous basal insulin and glucagon secretion in man. Diabetes 31: 22

    PubMed  CAS  Google Scholar 

  • Lauritzen T, Pramming S, Deckert T, Binder C (1983) Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 24: 326–329

    Article  PubMed  CAS  Google Scholar 

  • Lean ME, Ng LL, Tennison BR (1985) Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.BMJ (Clin Res Ed) 290: 105–108

    PubMed  CAS  Google Scholar 

  • Linn T, Ortac K, Laube H, Federlin K (1996) Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve. Metabolism 45: 1508–1513

    Article  PubMed  CAS  Google Scholar 

  • Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M (2002) Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 141: 490–495

    Article  PubMed  Google Scholar 

  • Lohmüller G (2001) Diabetes mellitus: Pumpentherapie Handbuch für Anwender und ihre Berater. Kirchheim, Mainz

    Google Scholar 

  • Lteif AN, Schwenk WF (1999) Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 22: 137–140

    PubMed  CAS  Google Scholar 

  • Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP (2001) Continuous subcutaneous insulin infusion therapy for children and adolescents:an option for routine diabetes care. Pediatrics 107: 351–356

    Article  PubMed  CAS  Google Scholar 

  • Martha PM, Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM (1989) Alteration in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocr 69: 563

    PubMed  CAS  Google Scholar 

  • Mortensen HB, Robertson KJ, Aanstoot H-J et al. (1998) Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Diabet Med 15: 752–759

    Article  PubMed  CAS  Google Scholar 

  • Murphy NP, Keane SM, Ong KK, Ford ME, Edge JA, Dunger BD (2002) A randomized cross-over trial comparing insulin glargine plus lispro with NPH insulin plus soluble insulin in adolescents with type 1 diabetes.Diabetes 51(Suppl 2): A54

    Google Scholar 

  • Murthy DYN, Guthrie RA, Womack WN, Jackson RL (1969) Insulin binding in children with diabetes mellitus. Pedatrics 43: 558

    CAS  Google Scholar 

  • Olsson PO, Arnqvist H, Asplund J (1993) No pharmacokinetic effect of retaining the infusion site up to four days during continuous subcutaneous insulin infusion therapy. Diabet Med 10: 477–480

    PubMed  CAS  Google Scholar 

  • Periello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent)diabetes mellitus by decreasing hepatic (and extra-hepatic)sensitivity to insulin in the absence of insulin. Diabetologia 33: 52

    Article  Google Scholar 

  • Pfutzner A, Kustner E, Forst T et al.(1996) Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol Diabetes 104: 25–30

    Article  PubMed  CAS  Google Scholar 

  • Pickup J, Keen H (2002) Continuous subcutaneous insulin infusion at 25 years:evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25: 593–598

    PubMed  Google Scholar 

  • Pickup JC, Keen H, Parsons JA, Alberti KG (1978) Continuous subcutaneous insulin infusion:an approach to achieving normoglycaemia. Br Med J 1: 204–207

    Article  PubMed  CAS  Google Scholar 

  • Pickup J, Mattock M, Kerry S (2002) Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes:meta-analysis of randomised controlled trials. BMJ 324: 705

    Article  PubMed  CAS  Google Scholar 

  • Plotnick LP, Clark LM, Brancati FL, Erlinger T (2003) Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26: 1142–1146

    PubMed  Google Scholar 

  • Porcelati F, Rossetti P, Fanelli CG, Scionti L, Brunetti P, Bolli GB (2002) Glargine versus NPH as basal insulin in intensive treatment of T1DM given lispro at meals. Diabetes 51(Suppl 2): A53

    Google Scholar 

  • Raile K, Noelle V, Landgraf R, Schwarz HP (2002) Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII)therapy. J Pediatr Endocrinol Metab 15: 607–612

    PubMed  CAS  Google Scholar 

  • Raskin P, Holcombe JH, Tamborlane WV et al.(2001) A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump. J Diabetes Complications 15: 295–300

    Article  PubMed  CAS  Google Scholar 

  • Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA (2000) Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23: 639–643

    PubMed  CAS  Google Scholar 

  • Reichel A, Rietzsch H, Kohler HJ, Pfutzner A, Gudat U, Schulze J (1998) Cessation of insulin infusion at night-time during CSII-therapy:comparison of regular human insulin and insulin lispro. Exp Clin Endocrinol Diabetes 106: 168–172

    Article  PubMed  CAS  Google Scholar 

  • Renard E (2002) Implantable closed-loop glucose-sensing and insulin delivery:the future for insulin pump therapy. Curr Opin Pharmacol 2: 708–716

    Article  PubMed  CAS  Google Scholar 

  • Renner R, Hubert G, Lüddecke HJ, Liebl A (2002) Informationen zur Insulinpumpentherapie.Eine Broschüre nach den Inhalten der Insulinpumpenseminare des Diabeteszentrums am Klinikum München-Bogenhausen. 2. Aufl, Fa. Disetronic

    Google Scholar 

  • Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, Service FJ (1980) Control of blood sugar in insulin-dependent diabetes:comparison of an artificial endocrine pancreas,continuous subcutaneous insulin infusion,and intensified conventional insulin therapy. N Engl J Med 303: 1313–1318

    Article  PubMed  CAS  Google Scholar 

  • Rosenbloom AL, Frias JL (1974) Diabetes, short stature and joint stiffness — a new syndrome. Clin Res 22: 92 A

    Google Scholar 

  • Rosenbloom AL, Giordano BP (1977) Chronic overtreatment with insulin in children and adolescents. Am J Dis Child 131: 881

    PubMed  CAS  Google Scholar 

  • Rosenbloom AL, Silverstein J (1996) Connective tissue and joint disease in diabetes mellitus. Endocrin Metab Clin North Am 25: 463–472

    Article  Google Scholar 

  • Sackey AH, Jefferson IG (1994) Interval between insulin injection and breakfast in diabetes. Arch Dis Child 71: 248–250

    Article  PubMed  CAS  Google Scholar 

  • Saha ME, Huuppone T, Mikael K, Juuti M, Komulainen J (2002) Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 15: 1005–1010

    PubMed  CAS  Google Scholar 

  • Schmidt MI, Nadiji-Georgopoulos A, Rendell M, Margolis S, Kowarski A (1981) The dawn phenomenon, an early morning glucose rise; implications for diabetic instability. Diabetes Care 4: 579–585

    PubMed  CAS  Google Scholar 

  • Shade D, Santiago J, Skyler J, Rizza R (1983) Intensive insulin therapy. Excerpta Medica, Amsterdam

    Google Scholar 

  • Siegel L, Schachner H, Vargas I, Goland R (2001) Continuous subcutaneous insulin infusion therapy in young children with type-1 diabetes. Diabetes 50(Suppl 2): A67

    Google Scholar 

  • Simon C, Brandenberger G, Follenius M (1987) Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrititon. J Clin Endocrinol Metab 64: 669

    PubMed  CAS  Google Scholar 

  • Somogyi M (1959) Exacerbation of diabetes by excess insulin action. Amer J Med 26: 169

    Article  PubMed  CAS  Google Scholar 

  • Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR (1995) Continuous subcutaneous insulin infusion (CSII)in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 27: 199–204

    Article  PubMed  CAS  Google Scholar 

  • Stolte K, Woff J (1939) Die Behandlung der kindlichen Zuckerkrankheit bei freigewählter Kost. Erg Inn Med Kinderheilk 56: 154–193

    Google Scholar 

  • Sulli N, Shashaj B (2003)Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 16: 393–399

    PubMed  CAS  Google Scholar 

  • Tamborlane WV, Sherwin RS, Genel M, Felig P (1979) Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med Mar 300: 573–578

    Article  CAS  Google Scholar 

  • Tattersall RB, Lowe J (1981) Diabetes in adolescence. Diabetologia 20: 517–523

    Article  PubMed  CAS  Google Scholar 

  • The Scottish Study Group for the care of the young diabetic (2001) Factors influencing glycemic control in young people with type 1 diabetes in Scotland. Diabetes Care 24: 239–244

    Google Scholar 

  • Thurm U (1999) Insulinpumpenfiebel oder... bei Dir piepts ja. 3. Aufl, Fa. Disetronic

    Google Scholar 

  • Travis LB (1975) “Overcontrol” of juvenile diabetes mellitus. South Med J 68: 767

    PubMed  CAS  Google Scholar 

  • Waldhäusl W (1989) Circadian rhythms of insulin needs and actions. Diabetes Res Clin Pract 6: 17

    Article  Google Scholar 

  • Waldhäusl W, Bratusch-Marrain P (1987) Factors regulating the disposal of an oral glucose load in normal,diabetic and obese subjects. Diabetes Metab Rev 3: 79

    Article  PubMed  Google Scholar 

  • Waldhäusl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P (1979) Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221–227

    Article  PubMed  Google Scholar 

  • Waldhäusl WK, Gasic S, Bratusch-Marrain P, Nowotny P (1983) The 75-g oral glucose tolerance test:effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25: 489

    Article  PubMed  Google Scholar 

  • Weintrob N, Benzaquen H, Galatzer A et al.(2003) Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 112 (3 Pt 1): 559–564

    Article  PubMed  Google Scholar 

  • White NH, Hollander AS, Sadler M, Daniels L (2001) Risks and benefits of continuous subcutaneous insulin infusion (CSII)therapy in children. Diabetes 50(Suppl 2): A66

    Google Scholar 

  • Willi SM, Planton J, Egede L, Schwarz S (2003) Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 143: 796–801

    Article  PubMed  CAS  Google Scholar 

  • Winter RJ (1981) Profiles of metabolic control in diabetic children.Frequency of asymptomatic nocturnal hypo-glycemia. Metabolism 30: 666

    Article  PubMed  CAS  Google Scholar 

  • Wiemann D, Bretschneider D (1997) Insulinpumpentherapie im Kindes-und Jugendalter auch schon vor dem 16. Lebensjahr. Diabetes Stoffw 6(Suppl1): 59 (Abstrakt)

    Google Scholar 

  • Wolpert HA, Faradji RN, Bonner-Weir S, Lipes MA (2002) Metabolic decompensation in pump users due to lispro insulin precipitation. BMJ 324: 1253

    Article  PubMed  Google Scholar 

  • Wolf J, Wolf E, Hürter P (1987) Intensivierte konventionelle Insulintherapie bei Kindern und Jugendlichen mit Typ I Diabetes. Monatsschr Kinderheilk 135: 770–774

    CAS  Google Scholar 

  • Yki-Jarvinen HA, Dressler K, Ziemen M (2000) Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23: 1130–1136

    PubMed  CAS  Google Scholar 

  • Zadik Z, Chalew SA, MacCarter J et al.(1985) The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrin Metab 60: 513–516

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2005). Ambulante Langzeitbehandlung. In: Diabetes bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-26602-X_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-26602-X_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21186-0

  • Online ISBN: 978-3-540-26602-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation